The insider sales are too small in dollar terms and relative to market cap to warrant a bearish read. Monitor for any larger insider sales or a change in the pattern, but this cluster alone does not suggest material negative information. The strong analyst consensus and positive historical T+20 drift for LGND filings suggest the stock's upward momentum may continue.
Price Chart
Executive Summary
Two insiders at Ligand Pharmaceuticals sold a combined $427K in open-market transactions over a one-week window. The sales are small relative to the $5.7B market cap (0.007%), and the cluster consists of a CLO and a director, not the CEO or CFO, limiting the informational signal. The sales are likely routine portfolio diversification rather than a bearish signal on the company's prospects, especially given the strong analyst consensus (94% bullish) and the company's recent positive historical performance pattern at T+20.
Key Financial Metrics
Key Facts
- Two insiders sold shares between Sept 3 and Sept 10, 2026
- Total sale value: $427K (0.007% of $5.7B market cap)
- Sellers: CLO Andrew Reardon ($85K) and Director Martine Zimmermann ($342K)
- No CEO or CFO sales in the cluster
- 94% of analysts rate the stock as Buy or Strong Buy
Financial Impact
Total insider sales of $427K represent a negligible 0.007% of market cap
Risk Factors
- Insider sales could accelerate if management becomes less confident
- The stock has high institutional ownership (BlackRock, Invesco, Vanguard) — any large fund trim could pressure shares
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-LGND-1789419701379 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 17d ago | Insider Cluster | $276.98 $298.50 | ▲ +7.77% | ▲ +5.66% | $302.96 (+9.38%) |
Aug 14, 2026 6w ago | Insider Cluster | $291.77 $280.18 | ▼ −3.97% | ▼ −2.78% | $302.96 (+3.84%) |
Aug 6, 2026 8w ago | 8-K | $300.14 $288.82 | ▼ −3.77% | ▼ −4.98% | $302.96 (+0.94%) |
Jun 25, 2026 14w ago | 8-K | $303.59 $319.55 | ▲ +5.26% | ▲ +3.09% | $302.96 (−0.21%) |
Jun 18, 2026 15w ago | Insider Cluster | $274.88 $295.92 | ▲ +7.65% | ▲ +9.32% | $302.96 (+10.22%) |
Jun 16, 2026 15w ago | Insider Cluster | $255.25 $279.44 | ▲ +9.48% | ▲ +11.71% | $302.96 (+18.69%) |
Jun 12, 2026 15w ago | Insider Cluster | $253.25 $262.17 | ▲ +3.52% | ▲ +4.91% | $302.96 (+19.63%) |
May 1, 2026 22w ago | Insider Cluster | $227.44 $221.41 | ▼ −2.65% | ▼ −5.00% | $302.96 (+33.20%) |
Apr 14, 2026 24w ago | Press Release | $232.34 $226.67 | ▼ −2.44% | ▼ −3.83% | $302.96 (+30.40%) |
Feb 26, 2026 31w ago | 8-K | $196.17 $206.27 | ▲ +5.15% | ▲ +6.28% | $302.96 (+54.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access